PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
Randomized, double blind, placebo controlled, prospective trial investigating the effect of erythropoietin in renal transplantation. The investigators postulate that erythropoietin reduces the risk of delayed graft function.
Epistemonikos ID: 9e7940636ec71c7f5e5372059b5bd0c1bba736c3
First added on: May 04, 2024